Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2003
12/18/2003US20030232398 Diagnosing mammary gland tumors via detection of increased concentrations of leptin (LEP), leptin receptor (LEPR) and catechol-O-methyltransferase genes (COMT)
12/18/2003US20030232391 Identification of kinase inhibitors
12/18/2003US20030232382 Method and apparatus for performing large numbers of reactions using array assembly
12/18/2003US20030232381 Fiber array and methods for using and making same
12/18/2003US20030232380 Probe array substrate for detecting target substrance
12/18/2003US20030232377 Based on fetal cells present in peripheral maternal blood; a method for isolating fetal cells from maternal blood
12/18/2003US20030232376 Determining interference or disturbance in the co-modulation mechanism between androgen receptor proteins and the coactivator arginine methyltransferase (HSRNAAM)
12/18/2003US20030232375 Has symptoms such as obesity, diabetes, hypogonadism, mental retardation, renal cancer and other renal abnormalities, retinopathy and polydactyly or limb deformities; used in diagnosis and therapy of BBS and in drug screening
12/18/2003US20030232374 Involved in pathogenesis of impaired detrusor contractility; useful in the diagnosis and treatment of DERP- related conditions such as impaired detrusor contractility, urinary retention, Alzheimer's disease, cardiovascular disease and
12/18/2003US20030232371 Methods for detecting methylated promoters based on differential DNA methylation
12/18/2003US20030232369 Useful in structural homology deduction, in developing and screening agents that affect the activity of eukaryotic RNA polymerase, and in designing modified forms of eukaryotic RNA polymerase
12/18/2003US20030232368 Method for detecting a molecular recognition by electrochemiluminescence
12/18/2003US20030232365 BDNF polymorphisms and association with bipolar disorder
12/18/2003US20030232364 Gene expression profiling of plasma cells from normal individual and patients with multiple myeloma and monoclonal gammopathy of undetermined significance
12/18/2003US20030232361 Preparing the arrays wherein impurities that can affect the variability and performance of the arrays are excluded from reagent solutions
12/18/2003US20030232360 An in vitro system that recapitulates regulated mRNA stability and turnover of exogenous RNA substrates; used to identify agents capable of modulating RNA turnover in the presence of RNA stability modifying agents
12/18/2003US20030232358 Identifying the genetic factors responsible for cell differentiation based on expression cloning
12/18/2003US20030232356 Skin cell biomarkers and methods for identifying biomarkers using nucleic acid microarrays
12/18/2003US20030232355 A compound containing a first and a second polymeric strands, and each strand includes a sequence of ligands covalently bound by linkeres, atleast one linker selected from an amide, thioamide, sulfinamide or sufonamide
12/18/2003US20030232354 Use of electron transfer moieties with different redox potentials to electronically detect nucleic acids, such as sequencing of DNA
12/18/2003US20030232353 Identification of genes that are present in two allelic forms and show differential expression of the different alleles; Useful to identify changes in imprinting status, to diagnose disease and to predict likehood of disease
12/18/2003US20030232352 Administering to an indivisual at risk of developing atherosclerosis, a lipopolysaccharide that modulates the function of TLR4 (Toll-Like Receptor 4) sufficient to effect the treatement of atherosclerosis
12/18/2003US20030232351 Methods for analyzing methylated CpG islands and GC rich regions
12/18/2003US20030232350 Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
12/18/2003US20030232349 Nucleic acid and amino acid sequences of proteases and the use of these sequences in the diagnosis and treatment of gastrointestinal, cardiovascular, autoimmune/inflammatory, cell proliferative, and neurological disorders
12/18/2003US20030232348 Extension of a locus specific capture probe followed by amplification of the extended capture probe using common primers
12/18/2003US20030232346 Measuring the distance between labeled nucleotides, such as nucleotides labeled with bulky groups
12/18/2003US20030232345 Biomolecule resistant surfaces and their methods of use in assays
12/18/2003US20030232344 Hybridization process for arrays
12/18/2003US20030232343 Test elements bound to a support introduced into a chamber, each test elment containing reaction and detection domains, a fluid reactive with reaction domains is introduced, analyzing locations fluid has not interacted with reaction domain
12/18/2003US20030232341 Identifying a selected nucleotide in a nucleic acid utilizing a mobile solid support
12/18/2003US20030232340 Nanoporous particle with a retained target
12/18/2003US20030232339 Human TRPCC cation channel and uses
12/18/2003US20030232337 Detection of Staphylococcus spp.
12/18/2003US20030232334 Novel compositions and methods for cancer
12/18/2003US20030232333 Cleaving single-stranded nucleic acid sequences at a desired location, using a restriction endonuclease that is active at the chosen temperature
12/18/2003US20030232330 Detection and identification of enteric bacteria
12/18/2003US20030232328 Method of detecting antibodies to HCV
12/18/2003US20030232327 Methods, kits and compositions pertaining to PNA Molecular Beacons
12/18/2003US20030232323 Identifying an agents which inhibit the interaction between a PD-1 ligand and a PD-1 polypeptide, from test agents, determining whether interaction is inhibited, and such agent unable to inhibit interaction, modulates immune response
12/18/2003US20030232322 Nitrate sensor
12/18/2003US20030232321 Useful for colorimetric detection of glucose in whole blood
12/18/2003US20030232074 For stimulating immune activation; for screening immunostimulatory compounds
12/18/2003US20030232054 Novel nucleic acids and polypeptides
12/18/2003US20030232044 Contacting sample comprising nucleic acid molecules with hybridization probe; detecting presence of nucleic acid molecule in sample that hybridizes to probe, thereby identifying nucleic acid associated with metabolic disorder
12/18/2003US20030232021 Method for the treatment of dental caries caused by streptococci mutans infection by inhibiting energy storage and utilization
12/18/2003US20030232014 Mass spectrometry-based procedure for detection of amino acid modifications, such as phosphorylation; drug discovery
12/18/2003US20030231791 Automated system for combining bright field and fluorescent microscopy
12/18/2003US20030231304 Metal coated nanocrystalline silicon as an active surface enhanced raman spectroscopy (SERS) substrate
12/18/2003US20030231294 Optical sensor and method for measuring concentration of a chemical constituent using its intrinsic optical absorbance
12/18/2003DE20121968U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle
12/18/2003DE20121967U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle
12/18/2003DE20121963U1 Nukleinsäuren für die Diagnose von mit Entwicklungsgenen assoziierten Krankheiten Nucleic acids for diagnosis of diseases associated with developmental genes
12/18/2003DE20121961U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle
12/18/2003CA2590618A1 Method of treating cancer using kinase inhibitors
12/18/2003CA2493890A1 Methods for using adamts-12, an integrin and metalloprotease with thrombospondin motifs
12/18/2003CA2489180A1 Method for mapping and eliminating t-cell epitopes
12/18/2003CA2489177A1 A disposable cartridge for characterizing particles suspended in a liquid
12/18/2003CA2489176A1 Lysing reagent, cartridge and automatic electronic cell counter for simultaneous enumeration of different types of white blood cells
12/18/2003CA2489083A1 Method for identifying agonists or antagonists for the g-protein coupled mas-like 1 receptor
12/18/2003CA2489050A1 Gp41 peptides and methods based-thereon for inhibiting hiv fusion to target cells
12/18/2003CA2488932A1 Transgenic mammals expressing polyglutamine
12/18/2003CA2488883A1 Method for identifying agonists or antagonists for the gpr45-like/gpr63 receptor
12/18/2003CA2488778A1 Assay to detect replication competent viruses
12/18/2003CA2488769A1 Composition and methods for obtaining nucleic acids from sputum
12/18/2003CA2488632A1 Type i interferon-inducible proteins to detect viral infection
12/18/2003CA2488629A1 Cancer-linked gene as target for chemotherapy
12/18/2003CA2488623A1 System and method for the preparation of arrays of biological or other molecules
12/18/2003CA2488413A1 Eef1a2 for use in the prognosis, diagnosis and treatment of cancer
12/18/2003CA2488382A1 Methods and compositions for detecting cancers
12/18/2003CA2488330A1 Improvements for combinatorial oligonucleotide pcr
12/18/2003CA2488227A1 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue
12/18/2003CA2487983A1 Method of treating cancer using kinase inhibitors
12/18/2003CA2487943A1 Methods of diagnosing & treating diabetes and insulin resistance
12/18/2003CA2487438A1 Methods of treating and diagnosing diabetes with cx3cr1 modulators
12/18/2003CA2487077A1 Isolated nucleic acid molecule encoding a novel centromere-associated motor protein, and uses thereof
12/18/2003CA2487045A1 Detection of epigenetic abnormalities and diagnostic method based thereon
12/18/2003CA2485874A1 T cell receptor cdr3 sequences and methods for detection
12/18/2003CA2485709A1 Novel screens to identify agents that modulate retinal blood vessel function and pericyte function and diagnostic and therapeutic application therefor
12/18/2003CA2480619A1 Novel oxidase
12/18/2003CA2480351A1 Improvements in and relating to a method of dna testing for mycobacterium paratuberculosis strains
12/18/2003CA2473321A1 Flavivirus vaccines
12/17/2003EP1371990A1 Microchip
12/17/2003EP1371988A2 Assay for the determination of the hormonal effect of compounds
12/17/2003EP1371985A2 Means and process for detecting and enriching microorganisms
12/17/2003EP1371736A1 Highly sensitive nested PCR detection scheme for efficient multiplex detection of members of Vitivirus, Foveavirus and Closterovirus genus in grapevine
12/17/2003EP1371735A1 Method of evaluating the extent of reaching the intestine of bifidobacterium in fermented milk food or drink
12/17/2003EP1371726A1 Method for amplifying RNA
12/17/2003EP1370870A2 Diagnostic screens for alzheimer's disease
12/17/2003EP1370863A2 Patch-clamping and its use in analysing subcellular features
12/17/2003EP1370696A2 Expression profiles and methods of use
12/17/2003EP1370694A2 Detection of methicillin-resistant staphylococcus aureus (mrsa)
12/17/2003EP1370693A2 Amplified cancer gene wip1
12/17/2003EP1370692A2 Methods for purifying and detecting double stranded dna target sequences by triple helix interaction
12/17/2003EP1370691A2 Method for detecting cytosine methylation patterns having high sensitivity
12/17/2003EP1370690A2 Arrays and methods of use
12/17/2003EP1370689A1 Molecular target validation method
12/17/2003EP1370688A1 Detecting interactions between oligonucleotides and rna using fluorescence resonance energy transfer (fret)
12/17/2003EP1370687A1 DETECTING BINDING OF mRNA TO AN OLIGONUCLEOTIDE ARRAY USING RNA DEPENDENT NUCLEIC ACID MODIFYING ENZYMES
12/17/2003EP1370686A2 Methods for global profiling gene regulatory element activity
1 ... 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 ... 3003